Studies related to Memory and Oxiracetam

The effects of oxiracetam (ISF 2522) in patients with organic brain syndrome (a double-blind controlled study with piracetam)
Effect Increase
Trial Design Double blind
Trial Length 1-6 months
Number of Subjects 60
Sex Both Genders
Age Range 65+
Notes for this study:
400mg oxiracetam (building up over 6 weeks to 2,400mg daily, which was then taken for another 6 weeks) was able to reduce symptoms of cognitive decline both subjectively and empirically while promoting memory formation in elderly persons with organic cognitive decline.

Full details on all 2 studies are available to Examine Members. Try out the Examine Membership with a 14-day free trial.

Already a Member? Log in now to access.